Real-world Radicava use in ALS tied to unexpected side effects: Data
ALS News Today - 07 May 2025Real-world Radicava use in ALS tied to unexpected side effects: Data ...
als
Real-world Radicava use in ALS tied to unexpected side effects: Data ...
Watch: Elon Musk's Neuralink patient makes YouTube video with brain implant
India Today - 06 May 2025Watch: Elon Musk's Neuralink patient makes YouTube video with brain implant ...
BrainStorm to Present Biomarker Insights Supporting NurOwn's Mechanism of Action and Clinical Impact at the 2025 ALS Drug Development Summit
PR Newswire - 06 May 2025BrainStorm to Present Biomarker Insights Supporting NurOwn's Mechanism of Action and Clinical Impact at the 2025 ALS Drug Development Summit ...
An ‘Impossible’ Disease Outbreak in the Alps
theatlantic.com - 23 Mar 2025An ‘Impossible’ Disease Outbreak in the Alps ...
Paralyzed man with ALS is third to receive NeuraLink implant, can type with brain
Fox News - 29 Apr 2025Paralyzed man with ALS is third to receive NeuraLink implant, can type with brain ...
Eric Dane Announces He Has Been Diagnosed with ALS (Exclusive)
People.com - 10 Apr 2025Eric Dane Announces He Has Been Diagnosed with ALS (Exclusive) ...
Third Neuralink brain implant patient able to communicate despite non-verbal ALS
Fox Business - 27 Apr 2025Third Neuralink brain implant patient able to communicate despite non-verbal ALS ...
Eric Dane steps out for first time since ALS reveal
Page Six - 15 Apr 2025Eric Dane steps out for first time since ALS reveal ...
Harvard researchers say they might have to lay off workers and euthanize research animals due to funding freeze
CNN - 16 Apr 2025Harvard researchers say they might have to lay off workers and euthanize research animals due to funding freeze ...
Eric Dane, McSteamy of ‘Grey’s Anatomy,’ Says He Has A.L.S.
The New York Times - 11 Apr 2025Eric Dane, McSteamy of ‘Grey’s Anatomy,’ Says He Has A.L.S. ...
Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly
Pharmafile - 07 May 2025Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly ...
VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston
BioSpace - 07 May 2025VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston ...
NeuroVoices: Brian Lin, PhD, on Targeted Therapies and Biomarkers to Drive New Momentum in ALS Research
Neurology live - 07 May 2025NeuroVoices: Brian Lin, PhD, on Targeted Therapies and Biomarkers to Drive New Momentum in ALS Research ...
Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m
PMLiVE - 07 May 2025Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m ...
Eli Lilly signs $415m deal for Alchemab’s ALS therapy
Pharmaceutical Technology - 06 May 2025Eli Lilly signs $415m deal for Alchemab’s ALS therapy ...
Eli Lilly licenses early-stage ALS drug program from Alchemab in $415M pact
Fierce Biotech - 06 May 2025Eli Lilly licenses early-stage ALS drug program from Alchemab in $415M pact ...
Lilly inks another antibody deal with Alchemab in ALS
FirstWord Pharma - 06 May 2025Lilly inks another antibody deal with Alchemab in ALS ...
Neuralink brain implant allows ALS patient to communicate
MobiHealthNews - 05 May 2025Neuralink brain implant allows ALS patient to communicate ...
The first nonverbal patient to receive Elon Musk's Neuralink shares a video he edited and narrated using his brain chip
Business Insider - 05 May 2025The first nonverbal patient to receive Elon Musk's Neuralink shares a video he edited and narrated using his brain chip ...